INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Recruiting · NCT07543367 · Registry updated 2026-05-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2026-05-11 | NCT07543367 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Synchron, Inc. | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Mayo Clinic | Jacksonville | United States | 122 |
| Mount Sinai Hospital | New York | United States | 225 |
| University of Buffalo Neurosurgery | Buffalo | United States | 3 |
| University of Pittsburgh Medical Center (UPMC) | Pittsburgh | United States | 10 |
| University of Texas Southwestern Medical Center (UTSW) | Dallas | United States | 3 |